CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-24 | Kihara James Principal Accounting Officer | Sale | −350 | $18.78 | $7K | 2,923 |
| 2023-02-24 | Schneyer Mark C. EVP, Chief Financial Officer | Sale | −577 | $18.78 | $11K | 4,118 |
| 2023-02-24 | KIM AUSTIN D. EVP,General Counsel, Secretary | Sale | −803 | $18.78 | $15K | 20,108 |
| 2023-02-24 | Teehan Brendan EVP, COO, Head of Commercial | Sale | −461 | $18.78 | $9K | 5,195 |
| 2023-02-23 | DAVIS STEPHEN CEO | Option exercise | +10,945 | 95,578 | ||
| 2023-02-23 | DAVIS STEPHEN CEO | Option exercise · Restricted Stock Units | −10,945 | 21,892 | ||
| 2023-02-23 | Kihara James Principal Accounting Officer | Option exercise | +840 | 3,273 | ||
| 2023-02-23 | Kihara James Principal Accounting Officer | Option exercise · Restricted Stock Units | −840 | 1,680 | ||
| 2023-02-23 | Schneyer Mark C. EVP, Chief Financial Officer | Option exercise | +1,353 | 4,695 | ||
| 2023-02-23 | Schneyer Mark C. EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −1,353 | 2,706 | ||
| 2023-02-23 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise | +2,214 | 20,911 | ||
| 2023-02-23 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise · Restricted Stock Units | −2,214 | 4,428 | ||
| 2023-02-23 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise | +1,107 | 5,656 | ||
| 2023-02-23 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise · Restricted Stock Units | −1,107 | 2,214 | ||
| 2023-02-10 | Williamson Douglas J Executive VP, Research & Dev | Grant or award · Non-Qualified Stock Option (Right to Buy) | +237,296 | 237,296 | ||
| 2023-02-10 | Williamson Douglas J Executive VP, Research & Dev | Grant or award · Restricted Stock Units | +50,655 | 50,655 | ||
| 2023-01-12 | Brege Laura Director | Option exercise | +12,500 | $17.01 | $213K | 12,500 |
| 2023-01-12 | Brege Laura Director | Sale | −12,500 | $18.25 | $228K | 0 |
| 2023-01-12 | Brege Laura Director | Option exercise · Stock Option (Right to Buy) | −12,500 | 0 | ||
| 2023-01-12 | BAKER BROS. ADVISORS LP Director | Option exercise | +15,000 | $5.22 | $78K | 3,521,613 |
Page 23 of 63 · 1,260 trades